Keith Stampher
Family Medicine · Colorado Springs, CONPI 1477764413
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 235 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 32 manufacturers, the largest accounting for just 18.0% — the pattern of someone who eats at a lot of different presentations. Reporting peaked in 2023 at $1,070 and has fallen 96.0% since, to $43 in 2025. Among family medicine clinicians in CO with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 235 payments — averaging $18.16 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AstraZeneca$766
- Boehringer Ingelheim$596
- Amgen$438
- AbbVie$437
- Lilly USA, LLC$316
- Novo Nordisk$284
- plus $1K from 26 others
What the payments were for
- Food & beverage$4,267100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AstraZeneca | 41 | $766 |
| Boehringer Ingelheim | 27 | $596 |
| Amgen | 25 | $438 |
| AbbVie | 20 | $437 |
| Lilly USA, LLC | 23 | $316 |
| Novo Nordisk | 17 | $284 |
| Esperion Therapeutics, Inc. | 10 | $183 |
| Pfizer | 8 | $133 |
| Otsuka America Pharmaceutical, Inc. | 7 | $132 |
| Johnson & Johnson | 7 | $111 |
| Takeda Pharmaceuticals U.S.A., Inc. | 5 | $101 |
| Kowa Pharmaceuticals America, Inc. | 6 | $95 |
| GSK | 5 | $84 |
| Exact Sciences | 5 | $72 |
| Biohaven Pharmaceuticals, Inc. | 3 | $61 |
| Nestle Healthcare Nutrition Inc. | 3 | $51 |
| Teva Pharmaceuticals USA, Inc. | 3 | $49 |
| Biohaven Pharmaceutical Holding Company Ltd. | 2 | $46 |
| Astellas Pharma US Inc | 2 | $42 |
| Merck | 2 | $30 |
| Eisai Inc. | 2 | $28 |
| Idorsia Pharmaceuticals US Inc | 2 | $27 |
| Sunovion Pharmaceuticals Inc. | 1 | $23 |
| Novartis | 1 | $22 |
| Ultragenyx Pharmaceutical Inc. | 1 | $20 |
| Paratek Pharmaceuticals, Inc. | 1 | $20 |
| Sanofi-aventis U.S. LLC | 1 | $17 |
| Redhill Biopharma Inc. | 1 | $17 |
| Shire North American Group Inc | 1 | $17 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 1 | $17 |
| Exeltis, USA Inc. | 1 | $16 |
| Inogen, Inc. | 1 | $16 |
How this compares
$4,267 in reported general payments places this provider in the 90th percentile of 2,079 family medicine providers in Colorado.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Lantus SolostarInsulin Glargine,hum.Rec.Anlog | 13 | $3,014 |
| Bisoprolol-HydrochlorothiazideBisoprolol/Hydrochlorothiazide | 35 | $1,206 |
| Atorvastatin Calcium | 127 | $1,096 |
| Tamsulosin Hcl | 55 | $984 |
| Levothyroxine Sodium | 90 | $906 |
| Omeprazole | 47 | $765 |
| Bumetanide | 13 | $726 |
| Albuterol Sulfate HfaAlbuterol Sulfate | 35 | $660 |
| Verapamil ErVerapamil Hcl | 13 | $603 |
| Ibuprofen | 36 | $563 |
| Triamterene-HydrochlorothiazidTriamterene/Hydrochlorothiazid | 49 | $556 |
| Rosuvastatin Calcium | 37 | $414 |
| Losartan Potassium | 41 | $402 |
| Bupropion XlBupropion Hcl | 11 | $389 |
| Metoprolol Succinate | 19 | $382 |
Paid to pharmacies, not to this prescriber.
Other family medicine in Colorado Springs
- Matthew YoungColorado Springs$270K
- Lawrence AndrewsColorado Springs$102K
- Elizabeth EricksonColorado Springs$31K
- Daniel RohwederColorado Springs$21K
- Gary TarshisColorado Springs$10K
- Jeremy BrownColorado Springs$8K
- Ethan LazarusDenver$688K
- Michael de NardisLarkspur$335K
- Mark DeutchmanDenver$258K
- Kari UusinarkausWoodland Park$254K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.